Project Grant R21AI180609
- This Project Grant award of $426,250.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), supports research to investigate the functions of two proteins, PEX4 and PEX22, in apicomplexan parasites. Apicomplexan parasites, such as Plasmodium falciparum (malaria) and Toxoplasma gondii (opportunistic infections), have major impacts on human health. The research team at Boston College will explore how...
- This $215,751 Project Grant was awarded on February 1, 2025 by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research to identify and characterize RNA-binding proteins (RBPs) and RNA-dependent proteins (RDPs) in the malaria parasite Plasmodium falciparum. The goals are to elucidate the importance of these proteins in parasite development and identify new pathways that can be...
- This Project Grant award of $299,954 was provided by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) to L2 Diagnostics LLC, a small business specializing in biomedical research and infectious disease interventions. The funding supports a Phase I feasibility study for the development of a novel peptide-based malaria vaccine called PFAG. The key objectives are to optimize the vaccine...
- The University of Georgia Research Foundation was awarded a $540,193 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The 12-month award, effective August 22, 2023, supports research to investigate the role of calcium-binding proteins and other secretory pathway components in the exocytosis of organelles critical for the invasion and egress of the malaria parasite Plasmodium falciparum...
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (CFDA 93.855 - Allergy and Infectious Diseases Research) provides $202,055.00 to Harvard T.H. Chan School of Public Health to characterize the Plasmodium falciparum apicomplexan amino acid transporter 2 (PFAPIAT2) and its role in proline transport for the malaria parasite. The key objectives are to investigate PFAPIAT2's function as a proline transporter that regulates proline levels in the blood stage and...
- This $501,800 Project Grant awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to understand the molecular mechanisms underlying the unique cell division process of the Plasmodium parasite that causes malaria. The principal investigator at The Children's Hospital Corporation (Boston Children's Hospital) will use cryo-electron tomography to study the parasite's basal complex, a...
- This $451,000 Project Grant, awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research federal grant program (CFDA 93.855), will support research to develop high-resolution arrays to study antibody responses to variants of the Plasmodium falciparum parasite, which causes malaria. Specifically, the award will leverage bioinformatic and laboratory methods recently developed by the awardee, The Regents of the University of...
- This $223,176 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research grant program (CFDA 93.855) to The Children's Hospital Corporation, doing business as Boston Children's Hospital. The grant supports research to understand the role of transmembrane proteins in Plasmodium cell division, which is critical for malaria parasite replication and survival. The research aims to use biochemical and microscopy...
- This $800,000 Project Grant, awarded by the National Science Foundation (NSF) Biological Sciences (CFDA 47.074) program, supports research to study the generation, maintenance, and function of extrachromosomal DNA (eDNA) in the malaria parasite Plasmodium. Key objectives include evaluating the connections between chromosomal genes and eDNA, the propensity for eDNA diversity, the cellular pathways and sequences contributing to eDNA generation and stability, and the clustering of eDNA within the...
- The National Institute of Allergy and Infectious Diseases (NIAID) awarded a $437,625 Project Grant titled "Understanding Plasmodium vivax Transmission Networks Through a Novel Microhaplotype and Kinship Analysis Approach" to Colorado State University. This 2-year grant, effective August 1, 2025, will support research to assess the effectiveness of reactive case detection (RCD) as a malaria control strategy in low transmission areas. The project aims to use highly multiplexed amplicon...
FUNCTIONAL CHARACTERIZATION OF THE PLASMODIUM FALCIPARUM INVASION LIGAND BINDOME - MALARIA REMAINS A MAJOR GLOBAL INFECTIOUS DISEASE THAT INFECTS HUNDREDS OF MILLIONS OF PEOPLE AND IS RESPONSIBLE FOR HUNDREDS OF THOUSANDS OF DEATHS ANNUALLY. TWO MAJOR SPECIES OF PARASITE, PLASMODIUM FALCIPARUM AND P. VIVAX ARE RESPONSIBLE FOR THE MAJORITY OF CLINICAL CASES. DURING THE COURSE OF A MALARIA INFECTION, PARASITES UNDERGO REPEATED CYCLES OF INVASION AND REPLICATION IN RED BLOOD CELLS (RBC) WHICH LEADS TO ALL SYMPTOM OF THE DISEASE. AN ESSENTIAL STEP IN THIS PROCESS IS PARASITE INVASION: A MATURE SCHIZONT WILL BURST RELEASING 16 - 20 MEROZOITES WHICH WILL BIND TO AND INVADE A NEW HOST RBC IN A PROCESS THAT TAKES LESS THAN A MINUTE. DURING THIS TIME, THE MEROZOITE DEPLOYS AN ARRAY OF INVASION LIGAND PROTEINS THAT FACILITATE THE DIFFERENT STEPS OF THE INVASION PROCESS. OVER 70 CANDIDATE P. FALCIPARUM INVASION LIGAND PROTEINS HAVE BEEN IDENTIFIED AND ARE THOUGHT TO BIND TO COGNATE HOST RECEPTOR PROTEINS ON THE SURFACE OF THE RBC. HOWEVER, TO DATE LESS THAN A THIRD OF THE CANDIDATE INVASION LIGAND PROTEINS HAVE BEEN DEMONSTRATED TO BIND TO RBCS AND EVEN FEWER HOST RECEPTORS HAVE BEEN IDENTIFIED. COMPREHENSIVE IDENTIFICATION OF A GLOBAL P. FALCIPARUM INVASION LIGAND BINDOME IS A MAJOR GAP IN THE FIELD AND WOULD GREATLY FACILITATE PRIORITIZING TARGETS FOR A BLOOD STAGE MALARIA VACCINE. HERE WE PROPOSE A NEW APPROACH: BIOTINYLATED SUPERNATANT ERYTHROCYTE BINDING ASSAY PROTEOMICS (BSEP) IN ORDER TO GLOBALLY IDENTIFY THE P. FALCIPARUM BINDOME. IN BSEP, PURIFIED SCHIZONT STAGE PARASITES ARE ALLOWED TO EGRESS IN PROTEIN FREE MEDIA TO GENERATE A SUPERNATANT ENRICHED IN INVASION LIGAND PROTEINS. THESE INVASION LIGAND PROTEINS ARE BIOTINYLATED, INCUBATED WITH RBCS WHICH ARE THEN SPUN THROUGH MINERAL OIL. BOUND PROTEINS ARE ELUTED VIA HIGH SALT TREATMENT, PURIFIED VIA STREPTAVIDIN BEADS AND SUBJECTED TO QUANTITATIVE TANDEM MASS-TAG BASED PROTEOMICS. IN THIS PROPOSAL WE AIM TO SYSTEMATICALLY DEVELOP THE BSEP PROTOCOL BY TESTING FOR THE OPTIMAL WAY TO GENERATE AND BIOTINYLATE PARASITE SUPERNATANTS, AND TO DETERMINE BINDING SPECIFICITY BY USING RBC BINDING SATURATION AND SUPERNATANT DEPLETION ASSAYS (WITH ANTIBODIES AGAINST KNOWN INVASION LIGANDS AS CONTROLS). WE WILL ALSO USE BSEP TO IDENTIFY INVASION LIGANDS BINDING TO CANDIDATE HOST RECEPTORS BY COMPARING THE BINDOMES BETWEEN WT AND CANDIDATE HOST RECEPTOR KNOCKOUTS GENERATED IN AN IMMORTALIZED ERYTHROID CELL LINE AND ALREADY AVAILABLE IN THE LAB. WE WILL VALIDATE THIS APPROACH USING THE WELL-KNOWN INTERACTION BETWEEN PFEBA175 INVASION LIGAND AND HOST GLYCOPHORIN A (GYPA) USING A GYPA KNOCKOUT. WE WILL USE A SIMILAR APPROACH WITH OUR CANDIDATE HOST RECEPTOR GLYCOPHORIN B (GYPB). GYPB IS THOUGHT TO INTERACT WITH PFEBL-1 INVASION LIGAND; HOWEVER, GYPB KNOCKDOWN RBCS SHOW A STRONG INVASION DEFECT WITH PARASITE STRAINS THAT HAVE EITHER WILD TYPE OR EBL-1 DELETIONS, THUS SUGGESTING THE PRESENCE OF AN ALTERNATIVE INVASION. WE WILL VALIDATE CANDIDATE INVASION LIGANDS BY RECOMBINANT EXPRESSION FOLLOWED BY FLOW CYTOMETRY BINDING ASSAYS WITH WT OR GYPB CELLS. ONCE ESTABLISHED, WE BELIEVE THAT THE BSEP APPROACH WILL RAPIDLY ENHANCE OUR UNDERSTANDING OF INVASION LIGAND/HOST RECEPTOR INTERACTIONS AND WOULD BE HIGHLY GENERALIZABLE TO OTHER MALARIA PARASITE SPECIES, INCLUDING P. VIVAX, ABOUT WHICH EVEN LESS IS KNOWN.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $160.1k | 6/18/25 | ||
| Not listed | ($160k) | 6/17/25 | ||
| Not listed | $199.4k | 3/28/25 | ||
| Not listed | $199.4k | 3/28/25 | ||
| Not listed | $23.8k | 9/11/24 |